Table 1.
APS patients (n = 80) | ||
---|---|---|
No VKA (n = 30) | VKA (n = 50) | |
General characteristics | ||
Age, y | 46 ± 13 | 45 ± 15 |
Female sex | 27 (90) | 32 (64) |
Systemic lupus erythematosus | 8 (27) | 18 (36) |
Primary APS | 22 (73) | 32 (64) |
Secondary APS | 8 (27) | 18 (36) |
Laboratory parameters, % | ||
LA | 67 | 84 |
Anti-cardiolipin antibodies | 83 | 84 |
Anti-β2GPI antibodies | 50 | 67 |
Clinical symptoms | ||
Arterial thrombosis | 8 (27) | 19 (50) |
Venous thrombosis | 12 (40) | 31 (62) |
Small vessel thrombosis | 3 (10) | 17 (34) |
Arterial and venous thrombosis | 1 (3) | 10 (20) |
Early fetal loss, female patients | 3 (11) | 0 (0) |
Late fetal loss, female patients | 6 (22) | 5 (16) |
Placental complications, female patients | 2 (7) | 3 (9) |
Values represent n (%) of patients, unless otherwise indicated.